Smart-CKD/BP Study

CKD Clinical Trial

Official title:

Through Remote Management and Propaganda of Intelligent Mobile Phone, the Standard Rate of Blood Pressure Control and the Change of Renal Function Were Observed

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03501745
• Other study ID #: 20180330
• Status: Recruiting
• Phase: N/A
• First received: March 30, 2018
• Last updated: April 17, 2018
• Start date: May 2018
• Est. completion date: May 2019

Study information

• Verified date: March 2018
• Source: Affiliated Hospital of Qinghai University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Through remote management and propaganda of intelligent mobile phone, the standard rate of blood pressure control and the change of renal function were observed.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 2
• Est. completion date: May 2019
• Est. primary completion date: November 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

1. diagnosis in line with the 2012 international kidney disease: improving global outcomes (kidney disease improving global out-comes, KDIGO) of chronic kidney disease diagnosis standard of hypertension diagnosis, "China Hypertension Prevention Guide 2010" diagnostic criteria;

2. and will have the use of intelligent mobile phone, and a network connection;

3. at the age of 18-70.

Exclusion Criteria:

1. GFR<15 ml/min or start replacement therapy;

2. do not understand Chinese, do not understand Chinese;

3. malignant tumor patients;

4. have mental illness;

5. there is consciousness disorder.

Related Conditions & MeSH terms

• CKD

Intervention

Behavioral:
• WeChat
Through remote management and propaganda of intelligent mobile phone, the standard rate of blood pressure control and the change of renal function were observed.

Locations

Country	Name	City	State
China	Pengli Luo	Qinghai	Xining

Sponsors (1)

Lead Sponsor	Collaborator
Affiliated Hospital of Qinghai University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Control rate of blood pressure control	Average blood pressure of each patient ,thenStatistics of the number of blood pressure control standards .	1 year
Primary	Drug compliance	Take medications according to the doctor's advice	1 year